ROCK-IN-13

Overview

ROCK-IN-13 is a ROCK2 inhibitor with an IC 50 of 8 nM against human ROCK2 . ROCK-IN-13 has the potential for use in the research of diseases such as multiple sclerosis, glaucoma, and cardiovascular diseases.

Application

Products | Products > Disease Areas > Visual System Disease | Products > Disease Areas > Neurodegenerative Disease | Products > Disease Areas > Autoimmune Disease | Products > Disease Areas > Glaucoma | Products > Disease Areas > Multiple Sclerosis | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Signaling Pathways > TGF-beta/Smad | Products > Signaling Pathways > Stem Cell/Wnt | Products > Signaling Pathways > Cytoskeleton | Products > Research Areas > Neurological Disease | Products > Research Areas > Inflammation/Immunology | Products > Research Areas > Cardiovascular Disease | Products > Signaling Pathways > ROCK

Product Information

• Catalog No.: HY-116233
• CAS No.: 1219727-16-8
• Molecular Formula: C20H22N4O
• Molecular Weight: 334.41
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source